TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma.
Hu F, Hu C, He Y, Sun Y, Han C, Zhang X, Yu L, Shi D, Sun Y, Zhang J, Jiang D, Yang S, Yang K.
Hu F, et al. Among authors: yu l.
Biomedicines. 2025 Jan 9;13(1):151. doi: 10.3390/biomedicines13010151.
Biomedicines. 2025.
PMID: 39857735